#' Obtain the Kaufmann_MS data
#'
#' Obtain the multiple sclerosis PBMC CITE-seq data from Kaufmann \emph{et al.}
#' (2021).
#'
#'@details
#'CITE-seq of PBMCs from 31 multiple sclerosis (MS) patients and 31 matched
#'healthy controls.
#'
#'Kaufmann \emph{et al.} generated 61 PBMC CITE-seq samples, consisting of:
#'\itemize{
#' \item{18 samples from 9 patients with relapsing-remitting multiple
#' sclerosis (RRMS), sampled longitudinally with and without treatment with
#' natalizumab}
#' \item{1 sample from a RRMS patient undergoing treatment with natalizumab
#' (no untreated sample available)}
#' \item{Samples from 11 untreated RRMS patients}
#' \item{Samples from 10 untreated primary progressive multiple sclerosis
#' (PPMS) patients}
#' \item{Samples from 31 age- and sex-matched healthy individuals}
#'}
#'
#' Data were downloaded from
#' \url{https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE144744}
#'
#' Kaufmann \emph{et al.} also generated spatial transcriptomics profiles of
#' brain tissue from 6 MS patients and 4 control samples (available on request).
#'
#'@references
#'Kaufmann, Max, et al. "Identifying CNS-colonizing T cells as potential
#'therapeutic targets to prevent progression of multiple sclerosis."
#'Med 2.3 (2021): 296-312.
#'\doi{doi: 10.1016/j.medj.2021.01.006}
#'@export
Kaufmann_MS <- function(){

}
